Intraindividual Variation in Plasma 25-Hydroxyvitamin D Measures 5 Years Apart among Postmenopausal Women

Background: Current literature examining associations between vitamin D and chronic disease generally use a single assessment of 25-hydroxyvitamin D [25(OH)D], assuming the 25(OH)D concentration of an individual is consistent over time. Methods: We investigated the intraindividual variability between two measures of plasma 25(OH)D concentrations collected approximately five years apart (1997–2000 to 2002–2005) in 672 postmenopausal women participating in the Women's Health Initiative. Plasma 25(OH)D was assessed using the DiaSorin LIAISON® chemiluminescence immunoassay. The within-pair coefficient of variation (CV) was 4.9% using blinded quality control samples. Mean and SDs of 25(OH)D at the two time points were compared using a paired t test. An intraindividual CV and intraclass correlation coefficient (ICC) were used to assess intraindividual variability. A Spearman correlation coefficient (r) assessed the strength of the association between the two measures, and concordance in vitamin D status at two time points was compared. Results: Mean 25(OH)D concentrations (nmol/L) significantly increased over time from 60.0 (SD = 22.2) to 67.8 (SD = 22.2; P < 0.05). The CV was 24.6%, the ICC [95% confidence interval (CI)] was 0.59 (0.54–0.64), and the Spearman r was 0.61 (95% CI = 0.56–0.66). Greater concordance over five years was observed in participants with sufficient compared with deficient or inadequate baseline 25(OH)D concentrations (weighted kappa = 0.39). Reliability measures were moderately influenced by season of blood draw and vitamin D supplement use. Conclusion: There is moderate intraindividual variation in 25(OH)D concentrations over approximately five years. Impact: These data support the use of a one-time measure of blood 25(OH)D in prospective studies with ≤ five years of follow-up. Cancer Epidemiol Biomarkers Prev; 21(6); 916–24. ©2012 AACR.

[1]  D. Bikle,et al.  1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. , 1986, The Journal of clinical investigation.

[2]  K. Nakamura,et al.  Summer/winter differences in the serum 25-hydroxyvitamin D3 and parathyroid hormone levels of Japanese women , 2000, International journal of biometeorology.

[3]  J. Zerwekh Blood biomarkers of vitamin D status. , 2008, The American journal of clinical nutrition.

[4]  M. Szklo,et al.  Epidemiology: Beyond the Basics , 1999 .

[5]  D. Siscovick,et al.  Test-retest reliability of the Women's Health Initiative physical activity questionnaire. , 2009, Medicine and science in sports and exercise.

[6]  A. Kristal,et al.  Measurement characteristics of the Women's Health Initiative food frequency questionnaire. , 1999, Annals of epidemiology.

[7]  Correction: Reproducibility of Plasma and Urine Biomarkers among Premenopausal and Postmenopausal Women from the Nurses' Health Studies , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[8]  A. LaCroix,et al.  Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. , 2010, The American journal of clinical nutrition.

[9]  B. Dawson-Hughes,et al.  Regional changes in body composition by time of year in healthy postmenopausal women. , 1992, The American journal of clinical nutrition.

[10]  Garnet L Anderson,et al.  The Women's Health Initiative recruitment methods and results. , 2003, Annals of epidemiology.

[11]  Re Waller,et al.  Principles of Exposure Measurement in Epidemiology , 1994 .

[12]  E. Giovannucci,et al.  Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer , 2004, Cancer Causes & Control.

[13]  R. Jorde,et al.  Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. , 2010, American journal of epidemiology.

[14]  B. Boucher,et al.  Intestinal cholecalciferol absorption in the elderly and in younger adults. , 1978, Clinical science and molecular medicine.

[15]  R. Hayes,et al.  Long-term Variation in Serum 25-Hydroxyvitamin D Concentration among Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[16]  P. Vestergaard,et al.  Vitamin D and its binding protein Gc: Long‐term variability in peri‐ and postmenopausal women with and without hormone replacement therapy , 2006, Scandinavian journal of clinical and laboratory investigation.

[17]  B Rosner,et al.  Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. , 1992, American journal of epidemiology.

[18]  R. Langer,et al.  The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.

[19]  R. Genco,et al.  Clinical and community risk models of incident tooth loss in postmenopausal women from the Buffalo Osteo Perio Study. , 2010, Community dentistry and oral epidemiology.

[20]  M. McDowell,et al.  Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). , 2011, NCHS data brief.

[21]  Kate McCormick,et al.  Quality assurance and control , 2002 .

[22]  M. Trevisan,et al.  The Association Between Osteoporosis and Alveolar Crestal Height in Postmenopausal Women. , 2005, Journal of periodontology.